复方丹参注射液治疗心肌缺血的临床观察

Clinical observation of salvia miltiorrhiza composite(SMC)on myocardial ischemia

目的 :观察复方丹参注射液并常规疗法对心肌缺血的治疗效果。方法 :将静息心电图具有缺血性ST—T改变的冠心病患者中以痰浊壅塞证为主的 46例和以心血瘀阻证为主的 44例患者分别随机平均分成治疗组和对照组。治疗组在常规治疗的基础上加复方丹参注射液 ;对照组予以常规治疗。结果 :2种证型治疗组均有较好疗效 ,而心血瘀阻型治疗组有效率与对照组比较有显著性差异。结论 :复方丹参制剂更适宜于符合心血瘀阻证的冠心病心电图缺血性ST—T改变患者。

Objective: It is to observe the effect of salvia miltiorrhiza composite (SMC) and routine treatment on myocardial ischemia. Methods: Among the patients of coronary heart disease (CHD) with ischemia ST-T changing on ECG, 46 patients with phlegmturbid stagnation(PTS)syndrome type and 44 patients with heart blood stasis(HBS)syndrome type were randomly divided into treatment group and control group. The patients in treatment group were treated with SMC based on routine treatment. The patients in control group were only treated with routine treatment. Results: Both syndrome types of the treatment group achieved good effects. Among the patients of HBS, treatment group gained better effects than control group.Conclusions: Among the patients of CHD ischemia with ST-T changing on ECG, SMC is more effective to HBS syndrome type.